glp-1 white house Trump administration announces deal to lower weight loss drug prices for many Americans major insurance changes are coming

Belonging to a new class of antidiabetic treatments that combine a basal insulin and a GLP-1R agonist, Xultophy is a once-daily combination of Tresiba (insulin degludec 100 units/mL) and Victoza (liraglutide) 3.6 mg/mL injection

Front Endocrinol 11:178 Marso SP, Daniels GH, Brown-Frandsen K, et al (2016) Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Some other drug classes (amylin & SGLT-2 inhibitors) can also produce modest weight loss

Access, Adherence, and the Real-World Picture The commercial arrival of oral GLP-1 weight loss medicines has introduced a new variable into the access and adherence conversation

This includes dedicated storage areas for hazardous waste, as well as traffic lanes and loading zones designed for a steady flow of tanker trucks delivering fresh solvents and hauling waste offsite